Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-κB activation and monocyte chemoattractant protein-1 synthesis

Journal of Immunology

Volumn 161, Issue 1, 1998, Pages 430-439

  Ruiz Ortega, Marta ^a   Bustos, Carmen ^a   Hernández Presa, Miguel A ^a   Lorenzo, Oscar ^a   Plaza, Juan J ^a   Egido, Jesús ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Renal Research Laboratory   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; QUINAPRIL;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL INFILTRATION; CELL MIGRATION; GENE EXPRESSION; HISTOPATHOLOGY; HORMONE ACTION; MESANGIUM CELL; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

ADMINISTRATION, ORAL; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; DOWN-REGULATION; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS; IMMUNE COMPLEX DISEASES; ISOQUINOLINES; KIDNEY GLOMERULUS; LEUKOCYTES, MONONUCLEAR; NF-KAPPA B; RATS; RATS, WISTAR; RNA, MESSENGER; TETRAHYDROISOQUINOLINES; UP-REGULATION;

EID: 0031858761     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Klahr, S., G. Schreiner, and I. Ichikawa. 1988. The progression of renal disease. N. Engl. J. Med. 318:1657.
2. Rovin, B. H., and G. F. Schreider. 1991. Cell-mediated immunity in glomerular disease. Annu. Rev. Med. 42:25.
3. Cattell V. 1994. Macrophages in acute inflammation. Kidney Int. 4:945.
4. Nikolic-Paterson, D. J., H. Y. Lan, P. A. Hill, and R. C. Atkins. 1994. Macro-phages in renal injury. Kidney Int. 45:579.
5. Gomez-Chiarri, M., A. Ortiz, D. Serón, E. Gonzalez, and J. Egido. 1993. The intercrine superfamily and renal disease. Kidney Int. 43:S81.
6. Schöndorff D. 1995. The rote of chemokines in the initiation and progression of renal disease. Kidney Int. 49:544.
7. Prodjosudjadi, W., J. S. J. Gerritsma, L. A. van Es, M. R. Daha, and J. A. Bruijn. 1995. Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. Clin. Nephrol 44:148.
8. Zoja, C., J. M. Wang, S. Bettoni, N. Sironi, D. Renzi, F. Chiffarino, H. E. Abbod, J. Van Damme, A. Mantovani, G. Remuzzi, and A. Rambaldi. 1991. Interleukin-1β and tumor necrosis factor-α induce gene production of leukocyte chemotactic factors, colony-simulating factors and interleukin-6 in human mesangial cells. Am. J. Pathol. 138:991.
9. Rovin, B. H., M. Rumancik, L. Tan, and J. Dickerson. 1993. Glomerular expression of monocyte chemoattractant protein-1 by cultured human mesangial cells. J. Immunol. 148:1036.
10. Satriano, J. A., K. Hora, Z. Shan, E. R. Stanley, T. Mori, and D. Schlondorff. 1993. Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulation factor-1 by IFN-γ, tumor necrosis factor-α, IgG aggregates and cAMP in mouse mesangial cells. J. Immunol. 150:1971.
11. Hora, K., J. A. Satriano, A. Santiago, T. Mori, and E. R. Stanley. 1992. Receptors for IgG complexes activates synthesis of monocyte chemoattractant protein-1 and colony stimulating factor-1. Proc. Natl. Acad. Sci. USA 89:1745.
12. Schmouder, R. L., R. M. Stricter, and S. L. Kunkel. 1993. Interferon-γ regulation of human renal cortical epithelial cell-derived monocyte chemotactic peptide-1. Kidney Int. 44:43.
13. González-Cuadrado, S., C. Bustos, M. Ruiz-Ortega, A. Ortiz, C. Guijarro, J. J. Plaza, and J. Egido. 1996. Expression of leukocyte chemoattractants by interstitial renal fibroblasts: up-regulation by drugs associated with interstitial fibrosis. Clin. Exp. Immunol. 106:518.
14. Rovin, B. H., M. Rumanick, L. Tan, and J. Dickerson. 1994. Glomerular expression of monocyte chemotactic peptide-1 in experimental and human glomerulonephritis. Lab. Invest. 71:536.
15. Satriano, J., and D. Schlondorff. 1994. Activation and attenuation of transcription factor NF-κB in mouse glomerular mesangial cells in response to tumor necrosis factor-α, immunoglobulin G, and adenosine 3′:5′-cyclic monophosphate. J. Clin. Invest. 94:1629.
16. Ueda, A., K. Okuda, S. Ohno, A. Shirai, T. Igarashi, K. Matsunaga, J. Fukushima, S. Kawamoto, Y. Ishigatsubo, and T. Okubo. 1994. NF-κB and SP1 regulate transcription of the human monocyte chemoattractant protein 1 gene. J. Immunol. 153:2052.
17. Grimm, S., and P. A. Baeuerle. 1993. The inducible transcription factor NF-κB: structure-function relationship of its protein subunits. Biochem. J. 290:297.
18. Bauerle, P. A., and D. Baltimore. 1988. I-κB: a specific inhibitor of the NF kappa B transcription factor. Science 242:540.
19. Henkel, T., T. Machleidt, I. Alkalay, M. Kranke, Y. Ben-Neriah, and P. A. Baeuerle. 1993. Rapid proteolysis of I-κ B-α is necessary for activation of the transcription factor NF-κB. Nature 365:182.
20. Egido, J. 1996. Vasoactive hormones and renal sclerosis (Nephrology Forum). Kidney Int. 49:578.
21. Wolf, G., and E. G. Neilson. 1993. Angiotensin II as a hypertrophogenic cytokine for proximal tubular cells. Kidney Int. 43:S100.
22. Ruiz-Ortega, M., and J. Egido. 1997. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int. 52:1497.
23. Shimada, K., and Y. Yakazi. 1978. Binding sites of angiotensin II in human mononuclear leukocytes. J. Biochem. 84:1013.
24. Goetzel, E. J., L. B. Klickstein, K. W. K. Watt, and B. U. Wintroub. 1980. The preferential human mononuclear leukocyte chemotactic activity of the substituent tetrapeptides of angiotensin II. Biochem. Biophys. Res. Commun. 97:1097.
25. Weinstock, J. V., A. M. Blum, and J. T. Kassab. 1987. Angiotensin II is a chemotactic for a T-cell subset which can express migration inhibition factor activity in murine schistosomiasis mansoni. Cell. Immunol. 107:180.
26. Brunner, H. R. 1992. ACE inhibitors in renal disease. Kidney Int. 42:463.
27. Ruiz-Ortega, M., S. González-Cuadrado, D. Serón, E. Condom, C. Bustos, R. Largo, E. González, and J. Egido. 1995. ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int. 48:1778.
28. Ishidoya, S., J. Morrissey, R. McCracken, A. Reyes, and S. Klahr. 1995. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int. 47:1285.
29. Sánchez-Crespo, M., F. Alonso, A. Barat, and J. Egido. 1982. Rat serum sickness: possible role of inflammatory mediators allowing deposition of immune complexes in the glomerular basement membrane. Clin. Exp. Immunol. 49:631.
30. Eddy, A. A., G. S. Crary, and A. F. Michael. 1986. Identification of lymphohemopoietic cells in the kidneys of normal rats. Am. J. Pathol. 124:335.
31. Gómez-Guerrero, C., M. J. Lopez-Armada, E. González, and J. Egido. 1994. Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-α and IL-6, and proliferation. J. Immunol. 153: 5247.
32. Mené, P., M. S. Simonson, and M. J. Dunn. 1989. Physiology of the mesangial cell. Physiol. Rev. 69:1347.
33. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
34. Yoshimura, T., M. Takeya, and K. Takahashi. 1991. Molecular cloning of rat monocyte chemoattactant protein-1 (MCP-1) and its expression in rat spleen cells and tumor cell lines. Biochem. Biophys. Res. Commun. 174:504.
35. Fort, P., L. Marty, M. Piezchaczyk, S. E. Sabrouty, C. Dani, P. Jeanteur, and J. M. Blanchard. 1985. Various rat adult tissues express only one mayor mRNA species from glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1431.
36. Negoro, N., Y. Kanayama, M. Haraguchi, N. Umetani, M. Nishimura, Y. Konishi, J. Iwai, M. Okamura, T. Inoue, and T. Takeda. 1995. Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. J. Clin. Invest. 95:1140.
37. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription inititation by RNA polymerase II in an soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
38. Liao, F., A. Andalibi, F. C. deBeer, A. M. Fogelman, and A. J. Lusis. 1993. Genetic control of inflammatory gene induction and NF-κB-like transcription factor activation in response to atherogenic diet in mice. J. Clin. Invest. 91:2572.
39. Baeuerle, P. A. 1991. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim. Biophys. Acta 1072:63.
40. Ortiz, A., J. Alonso, M. Gomez-Chiarri, J. L. Lerma, D. Seron, E. Condom, E. Gonzalez, and J. Egido. 1995. Fibronectin decreases glomerular lesions and synthesis of tumor necrosis factor-α, platelet-activating factor and fibronectin in proliferative glomerulonephritis. Clin. Exp. Immunol. 101:334.
41. Duque, N., C. Gómez-Guerrero, and J. Egido. 1997. Interaction of IgA with Fcα receptors of human mesangial cells activates transcription factor nuclear factor-κB and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10. J. Immunol. 159:3474.
42. Lovet, D. H., and R. B. Sterzel. 1986. Cell culture approaches to the analysis of glomerular inflammation. Kidney Int. 30:246.
43. Grande, J. P., M. L. Jones, C. L. Swenson, P. D. Killen, and J. S. Warren. 1994. Lipopolysaccharide induces monocyte chemoattractant protein production by rat mesangial cells J. Lab. Clin. Med. 124:12.
44. Bourcier, T., G. Sukhova, and P. Libby. 1997. The nuclear factor κB signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J. Biol. Chem. 272:15817.
45. Rovin, B. H., J. A. Dickerson, L. C. Tan, and C. A. Hebert. 1995. Activation of nuclear factor-κB correlates with MCP-1 expression by human mesangial cells. Kidney Int. 48:1263.
46. Schreck, R., B. Meier, D. N. Mannel, W. Droge, and P. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175:1181.
47. Johnson, R. J., C. E. Alpers, A. Yoshimura, D. Lombardi, P. Pritzl, J. Floege, and S. M. Schwartz. 1992. Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464.
48. Mai, M., H. Geiger, K. F. Hilgers, R. Veelken, J. F. E. Mann, J. Dämmrich, and F. Luft. 1993. Early interstitial changes in hypertension-induced renal injury. Hypertension 22:754.
49. Gräfe, M., W. Auch-Schwelk, K. Graf, H. Hertel, R. Hoffmann, P. Bartsch, V. Regitz-Zagrosek, A. Hildebrant, and E. Fleck. 1993. Induction of the adhesion molecule E-selectin in human cardiac endothelial cells by angiotensin II. Circulation 88:1316 (Abstr.).
50. Hahn, A. W. A., U. Jonas, F. R. Buhler, and T. J. Reskin. Activation of human peripheral monocytes by angiotensin II. 1994. FEBS Lett. 374:178.
51. Tang, W. W., M. Qi, and J. S. Warren. 1996. Monocyte chemoattractant protein-1 mediates glomerular macrophage infiltration in anti-GBM Ab GN. Kidney Int. 50:665.
52. Ruiz-Ortega, M., N. Duque, C. Gómez-Guerrero, and J. Egido. 1996. Upregulation and redistribution of renin angiotensin system genes in the kidney of nor-motensive rats with immune complex nephritis. J. Am. Soc. Nephrol. 7:1745. (Abstr.).
53. Ullian, M. E., and S. L. Linas. 1990. Angiotensin II surface receptors coupling to inositol triphosphate formation in vascular smooth muscle cells. J. Biol. Chem. 265:195.
54. Yang, S. G., M. Saifeddine, A. Laniyonu, and M. D. Hollenberg. 1993. Distinct signal transduction pathways for angiotensin II in guinea pigs gastric smooth muscle: differential blockade by indomethacin and tyrosine kinase inhibitors. J. Pharmacol. Exp. Ther. 264:958.
55. Marrero, M. B., B. Schieffer, W. G. Paxton, L. Heerdt, B. C. Berk, P. Delafontaine, and K. E. Bernstein. 1995. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375:247.
56. Takeuchi, K., N. Nakemura, N. S. Cook, R. E. Pratt, and V. J. Dzau. 1990. Angiotensin II can regulate gene expression by the AP-1 binding sequence via a protein kinase C-dependent pathway. Biochem. Biophys. Res. Commun. 172:1189.
57. Hernández-Presa, M., C. Bustos, M. Ortego, J. Tuñón, G. Renedo, M. Ruiz-Ortega, and J. Egido. 1997. Angiotensin converting enzyme inhibition prevents arterial NF-KB activation, MCP-1 expression and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95:1532.
58. Newton, R., I. M. Adcock, and P. J. Barnes. 1996. Superinduction of NF-κB by actinomycin D and cycloheximide in epithelial cells. Biochem. Biophys. Res. Commun. 218:518.
59. Moriyama, T., M. Fujibayashi, Y. Fujiwara, T. Kaneto, C. Xia, I. Kamada, A. Ando, and N. Ueda. 1995. Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells J. Am. Soc. Nephrol. 6:95.
60. Suzuki, Y. J., M. Mizuno, and L. Packer. 1994. Signal transduction for nuclear factor-κB activation: proposed location of antioxidant-inhibitable step. J. Immunol. 153:5008.
61. Pun, P. L., M. L. Avantaggiati, V. L. Burgio, P. Chirillo, D. Collepardo, G. Natoli, C. Balsano, and M. Levrero. 1995. Reactive oxygen intermediates (ROIs) are involved in the intracellular transduction of angiotensin II signal in C2C12 cells. Ann. NY Acad. Sci. 752:394.
62. Laursen, J. B., S. Rajagopalan, Z. Galis, M. Tarpey, B. A. Freeman, and D. G. Harrison. 1997. Role of superoxide in Angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95:588.